Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) Sees Large Decrease in Short Interest

Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) saw a significant drop in short interest in the month of August. As of August 14th, there was short interest totaling 8,194 shares, a drop of 77.9% from the July 30th total of 37,127 shares. Based on an average trading volume of 64,625 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.2% of the shares of the stock are sold short.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in Regentis Biomaterials stock. AIGH Capital Management LLC acquired a new position in Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 300,000 shares of the company’s stock, valued at approximately $916,000. AIGH Capital Management LLC owned about 5.79% of Regentis Biomaterials at the end of the most recent quarter.

Regentis Biomaterials Price Performance

Shares of NYSEAMERICAN:RGNT opened at $2.09 on Wednesday. The firm has a fifty day moving average price of $2.77 and a two-hundred day moving average price of $2.97. Regentis Biomaterials has a one year low of $1.23 and a one year high of $15.50.

About Regentis Biomaterials

Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing tissue repair solutions which seek to restore the health. Regentis Biomaterials Ltd. is based in Herzliya, Israel.